InnovationRx is a valuable resource for staying up to date on the latest healthcare news. According to a recent report from J.P. Morgan, venture investments in biopharma and medtech are on the rise in 2024. Biopharma startups raised $6.6 billion in venture investments during the third quarter, with total investments expected to reach $27.7 billion for the year. On the other hand, medtech saw $5.1 billion in venture investments last quarter, with a total of $16.1 billion in investments so far this year.
One standout startup making waves in the healthcare industry is Qnovia, which is revolutionizing smoking cessation with a new device. Founded by Mario Danek, Qnovia has raised $35 million in funding and is aiming to become a key player in the $3 billion nicotine replacement therapy market. The company recently received approval for an investigational new drug application from the FDA and plans to start human clinical trials soon.
In other pipeline and deal updates, Protega Pharmaceuticals received FDA approval for Roxybond, a new oxycodone pill with abuse-deterrent technology for pain management. Antheia announced its first commercial delivery of drug ingredients manufactured through fermentation. Abbvie is set to acquire Alaida Therapeutics for $1.4 billion, focusing on central nervous system diseases. Monte Rosa therapeutics signed a collaboration deal with Novartis for the development of molecular degraders. Paragonix Technologies received FDA clearance for its KidneyVault system, while Innoventric raised $28.5 million for its prosthetic for tricuspid regurgitation. Agomab also secured $89 million in a series D round for fibrosis treatments, and Iterum Therapeutics received FDA approval for Orlynvah for urinary tract infections.
Cofertility is another startup making waves by addressing the issues of timing, cost, and egg donation in the fertility business. The company allows young women to freeze their eggs for free in exchange for donating half of the eggs retrieved, addressing the need for affordable and accessible fertility services.
In other healthcare news, Humana reported a $480 million profit amid rising costs and Medicare enrollment, while Alignment Healthcare continues to lose money despite increased Medicare enrollment. Eli Lilly’s stock took a hit on disappointing earnings and Zepbound sales. Additionally, salad kits have been linked to potentially contaminated poultry, prompting Listeria warnings.
Overall, the healthcare industry is seeing significant advancements and investments in 2024, with startups like Qnovia and Cofertility leading the way in innovation and addressing key challenges in the sector. Stay tuned for more updates on the latest developments in healthcare.
